Monopar Therapeutics (MNPR) Stock Price & Financial Analysis
Monopar Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Monopar Therapeutics
What is the current stock price for MNPR?
As of the latest trading session, MNPR stock trades at $55.13. The 52-week range is $26.06–$105.00, with a day range of $53.99–$57.30.
What is the P/E ratio for MNPR?
The P/E ratio (Price-to-Earnings) for MNPR is shown in the Key Statistics section. This valuation metric helps compare Monopar Therapeutics Inc. to industry peers.
Does MNPR pay dividends?
Monopar Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MNPR?
Based on 6 analysts, the consensus for MNPR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of MNPR?
Monopar Therapeutics's market capitalization is $392.7M, classifying it as a small-cap company. Monopar Therapeutics operates in the Healthcare sector within the Biotechnology industry.